Correlation Between AbbVie and Eterna Therapeutics
Can any of the company-specific risk be diversified away by investing in both AbbVie and Eterna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Eterna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Eterna Therapeutics, you can compare the effects of market volatilities on AbbVie and Eterna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Eterna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Eterna Therapeutics.
Diversification Opportunities for AbbVie and Eterna Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between AbbVie and Eterna is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Eterna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eterna Therapeutics and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Eterna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eterna Therapeutics has no effect on the direction of AbbVie i.e., AbbVie and Eterna Therapeutics go up and down completely randomly.
Pair Corralation between AbbVie and Eterna Therapeutics
Given the investment horizon of 90 days AbbVie Inc is expected to generate 0.13 times more return on investment than Eterna Therapeutics. However, AbbVie Inc is 7.92 times less risky than Eterna Therapeutics. It trades about 0.49 of its potential returns per unit of risk. Eterna Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 18,995 in AbbVie Inc on December 6, 2024 and sell it today you would earn a total of 2,080 from holding AbbVie Inc or generate 10.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AbbVie Inc vs. Eterna Therapeutics
Performance |
| Timeline |
| AbbVie Inc |
| Eterna Therapeutics |
AbbVie and Eterna Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AbbVie and Eterna Therapeutics
The main advantage of trading using opposite AbbVie and Eterna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Eterna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eterna Therapeutics will offset losses from the drop in Eterna Therapeutics' long position.| AbbVie vs. Merck Company | AbbVie vs. Pfizer Inc | AbbVie vs. Eli Lilly and | AbbVie vs. Bristol Myers Squibb |
| Eterna Therapeutics vs. Arcus Biosciences | Eterna Therapeutics vs. Cullinan Oncology LLC | Eterna Therapeutics vs. Annexon | Eterna Therapeutics vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |